Chemrex subsidiary governance shake-up: four directors resign; new chairman appointed

BioNexus Gene Lab Corp

Four Chemrex officers/directors (Too Kam Tham, Liong Tai Tan, Wei Foong Lim, Kuan Yew Tan) resigned on Dec 19, 2025.
Matthew L. Barsing appointed as chairman of Chemrex board; brings tech and public-sector experience.
Chemrex governance review ongoing, assessing historical compliance, governance, and operational matters.
Chemrex exploring potential CDMO expansion as part of strategic shift toward biotech development.

item 8.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.